Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adultsCristina Tassorelli, Shuu‐Jiun Wang, Hans‐Christoph Diener et al.|Cephalalgia|2018Cited by 382
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migrainePeter J. Goadsby, Charly Gaul, Linda Wietecha et al.|Brain|2019Cited by 275
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth editionHans‐Christoph Diener, Jay Mandrekar, Michel D. Ferrari et al.|Cephalalgia|2019Cited by 235
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adultsHans‐Christoph Diener, Gisela M. Terwindt, Cristina Tassorelli et al.|Cephalalgia|2020Cited by 213
Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic: A comprehensive reviewEdoardo Caronna, Patricia Pozo‐Rosich, Thomas C. van den Hoek et al.|Cephalalgia|2023Cited by 55